2026-07-012 min
Ipamorelin: Receptor Pathway Map and Evidence Boundaries
An evidence-led Ipamorelin review focused on receptor pathway map, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review DeskEvidence notes
Human studies, mechanisms, safety signals, regulatory status, and the limits of each conclusion.
Open
2026-07-012 min
Ipamorelin: Terminology Audit and Evidence Boundaries
An evidence-led Ipamorelin review focused on terminology audit, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk2026-07-012 min
Modified GRF (1-29): Evidence Checklist and Evidence Boundaries
An evidence-led Modified GRF (1-29) review focused on evidence checklist, human-study limits, regulatory context and claim verification.
Reviewed by CJC Axis Editorial Team2026-07-012 min
Modified GRF (1-29): Research Gaps Map and Evidence Boundaries
An evidence-led Modified GRF (1-29) review focused on research gaps map, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk2026-06-302 min
Modified GRF (1-29): Glucose and Metabolic Context and Evidence Boundaries
An evidence-led Modified GRF (1-29) review focused on glucose and metabolic context, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk2026-06-302 min
Modified GRF (1-29): Healthy-Aging Claims and Evidence Boundaries
An evidence-led Modified GRF (1-29) review focused on healthy-aging claims, human-study limits, regulatory context and claim verification.
Reviewed by Clinical Trial Review Team2026-06-302 min
Modified GRF (1-29): Sleep Claims and Evidence Boundaries
An evidence-led Modified GRF (1-29) review focused on sleep claims, human-study limits, regulatory context and claim verification.
Reviewed by CJC Axis Editorial Team2026-06-302 min
Modified GRF (1-29): Recovery and Injury Claims and Evidence Boundaries
An evidence-led Modified GRF (1-29) review focused on recovery and injury claims, human-study limits, regulatory context and claim verification.
Reviewed by Endocrine Evidence Desk2026-06-292 min
Modified GRF (1-29): Body Composition Claims and Evidence Boundaries
An evidence-led Modified GRF (1-29) review focused on body composition claims, human-study limits, regulatory context and claim verification.
Reviewed by CJC Axis Editorial Team2026-06-292 min
Modified GRF (1-29): Adverse-Event Reporting and Evidence Boundaries
An evidence-led Modified GRF (1-29) review focused on adverse-event reporting, human-study limits, regulatory context and claim verification.
Reviewed by Regulatory Review Desk